바이오모아 (BioMoa) — ADC · Antibody

9268프로그램 35FDA 승인

0오늘 방문

572누적 방문

8122갱신 대기 S–CData Tier S/A/B차세대 1068HER2 breast 5456Antibody 2744CGT →Psoriasis →NSCLC 35FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

CGTBHOTFDACuratedFDABiologicVertexApproved

exagamglogene autotemcel (Casgevy, exa-cel, CTX001)

Sickle cell disease with recurrent VOCs; transfusion-dependent β-thalassemia · BCL11A enhancer (CRISPR/Cas9) → HbF

#BCL11AenhancerCRISPRCas9HbF#CGT#Approved#FDA승인#바이오모아추천+5

임상시험 9상태 APPROVED

AntibodystaleGlaxoSmithKlinePhase 2

Feladilimab (Feladilimab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2

효능 ORR 44%임상시험 9상태 RECRUITING

ADCBiologicstaleCSPC ZhongQi Pharmaceutical Tec…Phase 3

DP303c (DP303c)

HER2-positive Breast Cancer · Localized Advanced or Metastatic Gastric

#LocalizedAdvancedorMetastaticGas#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

임상시험 9상태 RECRUITING

ADCBiologicstaleRochePhase 2

Zanubrutinib, Polatuzumab vedotin and Rituximab (Zanubrutinib, Polatuzumab vedotin and Rituximab)

Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 9상태 ACTIVE

AntibodystaleMacroGenicsPhase 1

lorigerlimab (lorigerlimab)

Advanced Solid Tumor; Castration-Resistant Prostatic Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#항체#면역항체+3

임상시험 9상태 ACTIVE

CGTBiologicstaleKitePhase 2

Tecartus (Tecartus)

Acute Lymphoblastic Leukemia; Large B-cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#세포유전치료#CAR-T+3

효능 ORR 86%임상시험 9상태 RECRUITING

ADCBiologicstaleRochePhase 2

Zanubrutinib, Polatuzumab Vedotin, Rituximab (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 9상태 ACTIVE

ADCBiologicstaleThe Thai Lymphoma Study GroupPhase 2

B-MAD chemotherapy (B-MAD chemotherapy)

Extranodal NK/T-cell Lymphoma · Extranodal NK/T-cell Lymphoma

#ExtranodalNKT-cellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 33.3%임상시험 9상태 ACTIVE

CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 2

TCR-like CAR-T (TCR-like CAR-T)

Safety and Efficacy of TCR-like CAR-T · Safety and Efficacy of TCR-like CAR-T

#SafetyandEfficacyofTCR-likeCAR-T#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 9상태 RECRUITING

ADCBiologicstaleSeagen Inc.Phase 2

CHEP (CHEP)

Lymphoma; Adult T-Cell Leukemia/Lymphoma · Lymphoma

#Lymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 2%임상시험 9상태 RECRUITING

ADCBiologicstaleCelldex TherapeuticsPreclinical

glembatumumab vedotin (glembatumumab vedotin)

Metastatic gpNMB Expressing Triple Negative Breast Cancer · Melanoma

#Melanoma#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 21%임상시험 9상태 ACTIVE

CGTBiologicstaleTianjin Medical University Seco…Preclinical

Oncolytic Adenovirus H101 (Oncolytic Adenovirus H101)

Malignant Pleural Mesothelioma, Advanced · Malignant Pleural Mesothelioma, Advanced

#MalignantPleuralMesotheliomaAdva#CGT#Preclinical#세포유전치료#CAR-T+4

임상시험 9상태 RECRUITING

AntibodystaleXencor, Inc.Phase 2

XmAb20717 (XmAb20717)

Biliary Tract Cancer · Melanoma

#Melanoma#Antibody#Phase2#항체#면역항체+3

임상시험 9상태 RECRUITING

AntibodystalePfizerPhase 2

Elranatamab + lenalidomide + dexamethasone (Elranatamab + lenalidomide + dexamethasone)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2

효능 ORR 0%임상시험 9상태 DISCONTINUED

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Lasofoxifene (Lasofoxifene)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 9상태 RECRUITING

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Amcenestrant (Amcenestrant)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 42.3%임상시험 9상태 RECRUITING

ADCBiologicstaleDaiichi SankyoPhase 3

R-DXd (R-DXd)

Solid Cancer · Solid Cancer

#SolidCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1

임상시험 9상태 RECRUITING

CGTAAVBiologicNovartis PharmaceuticalsPhase 2

Rapcabtagene autoleucel (Rapcabtagene autoleucel)

ANCA Associated Vasculitis (AAV) · ANCA Associated Vasculitis (AAV)

#ANCAAssociatedVasculitisAAV#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 9상태 RECRUITING

CGTBiologicstaleNanjing IASO Biotechnology Co.,…Phase 2

Eque-cel (Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection, Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (Eque-cel))

Relapsed/Refractory Multiple Myeloma · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 9상태 RECRUITING

ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

R-DXd (Raludotatug Deruxtecan, Raludotatug Deruxtecan (R-DXd))

Gastrointestinal Cancer · Gastrointestinal Cancer

#GastrointestinalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 9상태 RECRUITING

ADCBiologicstaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab Mafodotin-Blmf)

Multiple Myeloma; Multiple Myeloma in Relapse · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 6%임상시험 9상태 RECRUITING

CGTAAVBHOTFDACuratedFDABiologicBioMarinB-domain deleted FVIIIApproved

valoctocogene roxaparvovec (Roctavian, BMN 270, valoctocogene roxaparvovec-rvox)

Severe hemophilia A in adults · Factor VIII (AAV5)

#FactorVIIIAAV5#CGT#Approved#FDA승인#바이오모아추천+5

임상시험 8상태 APPROVED

AntibodystaleJanssenPhase 2

daratumumab (Darzalex, Daratumumab, dexamethasone, ixazomib, pomalidomide)

Relapsed Refractory Multiple Myeloma · FRα

#FR#Antibody#Phase2#항체#면역항체+3

임상시험 8상태 ACTIVE

ADCBiologicstaleAbbViePhase 3

Depatuxizumab mafodotin (Depatuxizumab mafodotin)

Glioblastoma · Glioblastoma

#Glioblastoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 14.3%임상시험 8상태 ACTIVE

ADCBiologicstaleGenmabApproved

TIVDAK (TIVDAK)

Cervical Cancer · Cervical Cancer

#CervicalCancer#ADC#Approved#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 23.8%임상시험 8상태 RECRUITING

38 / 167 페이지

← 이전 다음 →

전체 9,268개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 0 / 572

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

exagamglogene autotemcel (Casgevy, exa-cel, CTX001)

Feladilimab (Feladilimab)

DP303c (DP303c)

Zanubrutinib, Polatuzumab vedotin and Rituximab (Zanubrutinib, Polatuzumab vedotin and Rituximab)

lorigerlimab (lorigerlimab)

Tecartus (Tecartus)

Zanubrutinib, Polatuzumab Vedotin, Rituximab (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

B-MAD chemotherapy (B-MAD chemotherapy)

TCR-like CAR-T (TCR-like CAR-T)

CHEP (CHEP)

glembatumumab vedotin (glembatumumab vedotin)

Oncolytic Adenovirus H101 (Oncolytic Adenovirus H101)

XmAb20717 (XmAb20717)

Elranatamab + lenalidomide + dexamethasone (Elranatamab + lenalidomide + dexamethasone)

Lasofoxifene (Lasofoxifene)

Amcenestrant (Amcenestrant)

R-DXd (R-DXd)

Rapcabtagene autoleucel (Rapcabtagene autoleucel)

Eque-cel (Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection, Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (Eque-cel))

R-DXd (Raludotatug Deruxtecan, Raludotatug Deruxtecan (R-DXd))

belantamab mafodotin (Blenrep, GSK2857916, Belantamab Mafodotin-Blmf)

valoctocogene roxaparvovec (Roctavian, BMN 270, valoctocogene roxaparvovec-rvox)

daratumumab (Darzalex, Daratumumab, dexamethasone, ixazomib, pomalidomide)

Depatuxizumab mafodotin (Depatuxizumab mafodotin)

TIVDAK (TIVDAK)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

exagamglogene autotemcel (Casgevy, exa-cel, CTX001)

Feladilimab (Feladilimab)

DP303c (DP303c)

Zanubrutinib, Polatuzumab vedotin and Rituximab (Zanubrutinib, Polatuzumab vedotin and Rituximab)

lorigerlimab (lorigerlimab)

Tecartus (Tecartus)

Zanubrutinib, Polatuzumab Vedotin, Rituximab (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

B-MAD chemotherapy (B-MAD chemotherapy)

TCR-like CAR-T (TCR-like CAR-T)

CHEP (CHEP)

glembatumumab vedotin (glembatumumab vedotin)

Oncolytic Adenovirus H101 (Oncolytic Adenovirus H101)

XmAb20717 (XmAb20717)

Elranatamab + lenalidomide + dexamethasone (Elranatamab + lenalidomide + dexamethasone)

Lasofoxifene (Lasofoxifene)

Amcenestrant (Amcenestrant)

R-DXd (R-DXd)

Rapcabtagene autoleucel (Rapcabtagene autoleucel)

Eque-cel (Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection, Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (Eque-cel))

R-DXd (Raludotatug Deruxtecan, Raludotatug Deruxtecan (R-DXd))

belantamab mafodotin (Blenrep, GSK2857916, Belantamab Mafodotin-Blmf)

valoctocogene roxaparvovec (Roctavian, BMN 270, valoctocogene roxaparvovec-rvox)

daratumumab (Darzalex, Daratumumab, dexamethasone, ixazomib, pomalidomide)

Depatuxizumab mafodotin (Depatuxizumab mafodotin)

TIVDAK (TIVDAK)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

exagamglogene autotemcel (Casgevy, exa-cel, CTX001)

Feladilimab (Feladilimab)

DP303c (DP303c)

Zanubrutinib, Polatuzumab vedotin and Rituximab (Zanubrutinib, Polatuzumab vedotin and Rituximab)

lorigerlimab (lorigerlimab)

Tecartus (Tecartus)

Zanubrutinib, Polatuzumab Vedotin, Rituximab (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

B-MAD chemotherapy (B-MAD chemotherapy)

TCR-like CAR-T (TCR-like CAR-T)

CHEP (CHEP)

glembatumumab vedotin (glembatumumab vedotin)

Oncolytic Adenovirus H101 (Oncolytic Adenovirus H101)

XmAb20717 (XmAb20717)

Elranatamab + lenalidomide + dexamethasone (Elranatamab + lenalidomide + dexamethasone)

Lasofoxifene (Lasofoxifene)

Amcenestrant (Amcenestrant)